Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 42, 2012, Pages 16998-17003

  Farfán Arribas, Diego J ^a   Stern, Lawrence J ^a   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Immunology; Infection; Virology

Indexed keywords

INTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALYSIS; DEFECTIVE RIBOSOMAL PRODUCT; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS;

ANIMALS; ANTIGEN PRESENTATION; CATALYSIS; CELL LINE; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE; GENES, MHC CLASS I; IMMUNOLOGIC SURVEILLANCE; INTEINS; MICE; MICE, TRANSGENIC; PEPTIDE BIOSYNTHESIS; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME;

EID: 84867655637     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1210271109     Document Type: Article

References (44)

1. Goldberg AL, Dice JF (1974) Intracellular protein degradation in mammalian and bacterial cells. Annu Rev Biochem 43:835-869.
2. Hershko A, Ciechanover A (1992) The ubiquitin system for protein degradation. Annu Rev Biochem 61:761-807.
3. Rock KL, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771. (Pubitemid 24294452)
4. Yewdell JW, Antón LC, Bennink JR (1996) Defective ribosomal products (DRiPs): A major source of antigenic peptides for MHC class I molecules? J Immunol 157:1823-1826. (Pubitemid 126449651)
5. Boon T, Van Pel A (1989) T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29:75-79. (Pubitemid 19047297)
6. Schubert U, et al. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774. (Pubitemid 30212405)
7. Vabulas RM, Hartl FU (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310:1960-1963. (Pubitemid 43005990)
8. Reits EA, Vos JC, Grommé M, Neefjes J (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774-778. (Pubitemid 30212406)
9. Khan S, et al. (2001) Cutting edge: Neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol 167:4801-4804. (Pubitemid 33009706)
10. Qian S-B, et al. (2006) Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol 177:227-233. (Pubitemid 43939134)
11. Dolan BP, et al. (2011) Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J Immunol 186:2065-2072.
12. Yewdell JW, Nicchitta CV (2006) The DRiP hypothesis decennial: Support, controversy, refinement and extension. Trends Immunol 27:368-373. (Pubitemid 44038666)
13. Dolan BP, Knowlton JJ, David A, Bennink JR, Yewdell JW (2010) RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: A role for nuclear translation in defective ribosomal product synthesis? J Immunol 185:6728-6733.
14. Pierre P (2005) Dendritic cells, DRiPs, and DALIS in the control of antigen processing. Immunol Rev 207:184-190.
15. van der Bruggen P, Van den Eynde BJ (2006) Processing and presentation of tumor antigens and vaccination strategies. Curr Opin Immunol 18:98-104.
16. Dolan BP, Bennink JR, Yewdell JW (2011) Translating DRiPs: Progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci 68:1481-1489.
17. Sijts EJAM, Kloetzel PM (2011) The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci 68:1491-1502.
18. Apcher S, et al. (2011) Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci USA 108:11572-11577.
19. Neefjes J, Jongsma MLM, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823-836.
20. Apcher S, Manoury B, Fåhraeus R (2012) The role of mRNA translation in direct MHC class I antigen presentation. Curr Opin Immunol 24:71-76.
21. Paulus H (2000) Protein splicing and related forms of protein autoprocessing. Annu Rev Biochem 69:447-496.
22. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL (1993) A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552-554. (Pubitemid 23186643)
23. Okada CY, Rechsteiner M (1982) Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 29:33-41. (Pubitemid 12027669)
24. Moore MW, Carbone FR, Bevan MJ (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-785.
25. Grant EP, Michalek MT, Goldberg AL, Rock KL (1995) Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 155:3750-3758.
26. Qian S-B, Princiotta MF, Bennink JR, Yewdell JW (2006) Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem 281:392-400. (Pubitemid 43671200)
27. Perler FB, Xu MQ, Paulus H (1997) Protein splicing and autoproteolysis mechanisms. Curr Opin Chem Biol 1:292-299. (Pubitemid 127437154)
28. Apcher S, Fahraeus R, Manoury B (2004) Epstein-Barr virus: Exploiting the immune system by interfering with defective ribosomal products. Microbes Infect 6:1212-1218. (Pubitemid 39370090)
29. Chervin AS, et al. (2009) The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. J Immunol 183:1166-1178.
30. Herr RA, Wang X, Loh J, Virgin HW, Hansen TH (2012) Newly discovered viral E3 ligase pK3 induces endoplasmic reticulum-associated degradation of class I major histocompatibility proteins and their membrane-bound chaperones. J Biol Chem 287:14467-14479.
31. Rock KL, Gamble S, Rothstein L (1990) Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918-921.
32. Mackay LK, et al. (2009) T cell detection of a B-cell tropic virus infection: Newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display. PLoS Pathog 5:e1000699.
33. Leung CS, Haigh TA, Mackay LK, Rickinson AB, Taylor GS (2010) Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc Natl Acad Sci USA 107:2165-2170.
34. Mo XY, Cascio P, Lemerise K, Goldberg AL, Rock K (1999) Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J Immunol 163:5851-5859.
35. Kincaid EZ, et al. (2012) Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 13:129-135.
36. Kisielow P, Blüthmann H, Staerz UD, Steinmetz M, von Boehmer H (1988) Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+ 8+ thymocytes. Nature 333:742-746.
37. Gangopadhyay JP, Jiang S-Q, Paulus H (2003) An in vitro screening system for protein splicing inhibitors based on green fluorescent protein as an indicator. Anal Chem 75:2456-2462. (Pubitemid 36582832)
38. Elleuche S, Döring K, Pöggeler S (2008) Minimization of a eukaryotic mini-intein. Biochem Biophys Res Commun 366:239-243. (Pubitemid 50010678)
39. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-726. (Pubitemid 27305734)
40. Murali-Krishna K, et al. (1998) Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8:177-187. (Pubitemid 28123745)
41. Johnson KA, Simpson ZB, Blom T (2009) Global kinetic explorer: A new computer program for dynamic simulation and fitting of kinetic data. Anal Biochem 387:20-29.
42. Johnson KA, Simpson ZB, Blom T (2009) FitSpace explorer: An algorithm to evaluate multidimensional parameter space in fitting kinetic data. Anal Biochem 387:30-41.
43. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL (2001) 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 20:2357- 2366.
44. Kukutsch NA, Rossner S, Austyn JM, Schuler G, Lutz MB (2000) Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. J Invest Dermatol 115:449-453.